Aquila Investment Management’s Biogen BIIB Stock Holding History

Aquila Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$388K	Sell	2,000 -1,000	-33%	-$209K	0.43%	53
2024 Q2	$695K	Hold	3,000	–	–	0.65%	52
2024 Q1	$647K	Hold	3,000	–	–	0.55%	61
2023 Q4	$776K	Hold	3,000	–	–	0.67%	60
2023 Q3	$771K	Hold	3,000	–	–	0.71%	59
2023 Q2	$855K	Hold	3,000	–	–	0.7%	66
2023 Q1	$834K	Hold	3,000	–	–	0.69%	60
2022 Q4	$831K	Buy	3,000 +1,000	+50%	+$282K	0.64%	72
2022 Q3	$534K	Buy	+2,000	New	+$425K	0.4%	86

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aquila Investment Management's BIIB Position: Q3 2024 in Review

Aquila Investment Management reduced its Biogen (BIIB) stake by 33% in Q3 2024, selling an estimated $209K and leaving 2,000 shares worth $388K. The position accounts for 0.43% of the portfolio, ranked #53.

Aquila Investment Management first reported a position in BIIB in Q3 2022 and has held it in 9 quarters since. The position peaked at $855K in Q2 2023. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Aquila Investment Management held 2,000 shares of Biogen worth $388K as of Q3 2024.
Aquila Investment Management sold 1,000 Biogen shares in Q3 2024, an estimated $209K.
Biogen made up 0.43% of Aquila Investment Management's portfolio in Q3 2024, its #53 holding.
Aquila Investment Management first reported a position in Biogen in Q3 2022 and has held it in 9 quarters since.
Aquila Investment Management's Biogen position peaked at $855K in Q2 2023.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Aquila Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.